Mental Health Clinics in Maiden, NC Accepting Medicare
4 Mental Health Clinics found. Showing 1 - 4
 Catawba County Group Home #1 Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 401 N 4th Ave, Maiden, NC 28650 Phone: 828-695-5900 Fax: 828-695-4256 |
Guiding Light Counseling, Pllc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3568a Us-321 Bus, Maiden, NC 28650 Phone: 828-469-0220 Fax: 828-800-9335 |
Business Coaches & Consultants, Inc. Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 551 W Main St, Maiden, NC 28650 Phone: 828-638-8479 Fax: 855-888-3130 |
501 Special Union Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 704 Union St, Maiden, NC 28650 Phone: 828-428-4547 Fax: 704-864-2347 |
News Archive
MitoQ Targeted Antioxidant Dietary Supplement now available
MitoQ Limited is excited to announce the release of their newest offering, MitoQ Targeted Antioxidant Dietary Supplement. Published studies show that the supplement, which delivers the well known antioxidant CoQ to the mitochondria (our cellular power source) better than ever before, helps repair mitochondrial dysfunction, significantly reduces oxidative damage to cells and by association supports heart, liver and brain health while assisting in the increase of energy, libido and healthy aging.
Congress takes major step toward equitable payment for nurse-midwifery services
On Wednesday, the U.S. House of Representatives passed the "Children's Health and Medicare Protection Act of 2007 (CHAMP)" (H.R.3162), which expands health care coverage to pregnant women and their children and addresses a long-standing inequity in reimbursement for services of certified nurse-midwives (CNMs).
New nanodevice lays foundations for future development of novel therapies against aging
A team of Spanish scientists has developed an intelligent nanodevice that lays the foundations for the future development of new therapies against aging. The device consists of nanoparticles that can selectively release drugs in aged human cells.
Phase I clinical study evaluates safety and pharmacokinetics of ExeVir's COVID-19 neutralizing antibody
ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that the first subjects have been dosed in a Phase I clinical study of XVR011, its llama-derived antibody for the treatment and prevention of COVID-19.
› Verified 1 days ago